Song biological aims to become the world's leading innovative protein degradation of drugs - molecular glue type of small molecule drug research and development company. Composed of world-class management and scientific leaders with international vision and rich industry experience dage team
1
Funding Rounds
$22.0m
Money raised
The company Degron Therapeutics has raised a total of $22m in funding over 1 rounds.